Jeremy Er
Overview
Explore the profile of Jeremy Er including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrison S, Touzeau C, Kint N, Li K, Nguyen T, Mayeur-Rousse C, et al.
N Engl J Med
. 2025 Feb;
392(7):677-685.
PMID: 39938094
We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel (cilta-cel) in the phase 3 CARTITUDE-4 trial....
2.
Atkin-Smith G, Santavanond J, Light A, Rimes J, Samson A, Er J, et al.
Nat Commun
. 2024 Oct;
15(1):8802.
PMID: 39438460
Endothelial cells are integral components of all vasculature within complex organisms. As they line the blood vessel wall, endothelial cells are constantly exposed to a variety of molecular factors and...
3.
Bar N, Diels J, van Sanden S, Mendes J, Hernando T, Burnett H, et al.
Curr Med Res Opin
. 2024 Aug;
40(9):1597-1603.
PMID: 39129504
Objective: To estimate the comparative efficacy of ciltacabtagene autoleucel (cilta-cel) versus idecabtagene vicleucel (ide-cel) in patients with relapsed/refractory multiple myeloma (RRMM) treated with 2-4 prior lines of therapy. Methods: Matching...
4.
Sim B, Longhitano A, Er J, Harrison S, Slavin M, Teh B
Blood Cancer J
. 2023 Mar;
13(1):34.
PMID: 36894539
No abstract available.
5.
Beaumont S, Harrison S, Er J
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503289
Myeloma is a common haematological malignancy in which adverse skeletal related events are frequently seen. Over recent years, treatment for myeloma has evolved leading to improved survival. Antiresorptive therapy is...
6.
7.
Er J, Routledge D, Hempton J, Wood C, Joyce T, Harrison S, et al.
Intern Med J
. 2021 Feb;
51(2):280-283.
PMID: 33631863
There are currently limited Australian data on the outcomes of autologous stem cell transplantation (ASCT) in elderly multiple myeloma (MM) patients. We present the largest cohort of elderly MM patients...
8.
Er J, Wallis P, Maloney S, Norton R
J Paediatr Child Health
. 2014 Oct;
51(4):437-42.
PMID: 25316255
Aim: Bacteraemias in children are an important cause of morbidity and mortality. Knowledge of local epidemiology and trends is important to inform practitioners of likely pathogens in the sick child....